Guardian Pharmacy Services GRDN Accrued compensation and employee benefits

Accrued compensation and employee benefits at other companies

PACS GroupPACS

——

Revenue$336.6M+2.2%

Gross profit$76.3M+18.6%

Operating income$17.7M+35.9%

Net income$13.3M+40.7%

EPS (diluted)$0.21+40.0%

Cash & equivalents$64.9M+364%

Total debt$36.9M+29.6%

Total equity$232.4M+42.4%

Total assets$426.9M+27.8%

Operating cash flow$6.1M-65.5%

CapEx$495.0K-78.0%

Free cash flow$34.1M+69.8%

Market cap$2.48B+80.1%

Enterprise value$2.45B+76.1%

P/E46.8×—

P/S1.7×+0.6×

Gross margin20.9%+1.1pp

Operating margin5.3%—

Net margin3.6%+2.1pp

Return on equity26.8%—

Debt / equity0.2×0.0×

Current ratio1.5×+0.3×

Reported directly by Guardian Pharmacy Services in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.

The official record: Guardian Pharmacy Services’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Guardian Pharmacy Services's accrued compensation and employee benefits?: Guardian Pharmacy Services (GRDN) reported accrued compensation and employee benefits of -$2.26M in Q1 2026.
How has Guardian Pharmacy Services's accrued compensation and employee benefits changed year-over-year?: Guardian Pharmacy Services's accrued compensation and employee benefits increased by 42.9% year-over-year, from -$3.95M to -$2.26M.